Changes of Cell Adhesion Molecules and T Cell Subset Populations in Acute Myeloid Leukemia Patients Undergoing Intravenous Administration of Cytarabine Supplemented with Idarubicin

<div>The levels of sICAM-1, sVCAM-1, IL-10, and IL-35 measured by ELISA of serum samples in AML patients following intravenous administration of cytarabine supplemented with either idarubicin or daunorubicin.</div>

Journal of Chemistry

fig1

Figure 1

Figure 1: Changes of Cell Adhesion Molecules and T Cell Subset Populations in Acute Myeloid Leukemia Patients Undergoing Intravenous Administration of Cytarabine Supplemented with Idarubicin 

Figure 1 | Changes of Cell Adhesion Molecules and T Cell Subset Populations in Acute Myeloid Leukemia Patients Undergoing Intravenous Administration of Cytarabine Supplemented with Idarubicin 